Show simple item record

dc.contributor.authorCorsetti, Maura
dc.date.accessioned2024-03-20T11:00:42Z
dc.date.available2024-03-20T11:00:42Z
dc.date.issued2022
dc.identifier.citationSavarino, E., Zingone, F., Barberio, B., Marasco, G., Akyuz, F., Akpinar, H., Barboi, O., Bodini, G., Bor, S., Chiarioni, G., Cristian, G., Corsetti, M., Di Sabatino, A., Dimitriu, A.M., Drug, V., Dumitrascu, D.L., Ford, A.C., Hauser, G., Nakov, R., Patel, N., Pohl, D., Sfarti, C., Serra, J., Simren, M., Suciu, A., Tack, J., Toruner, M., Walters, J., Cremon, C. and Barbara, G. (2022) 'Functional bowel disorders with diarrhoea: Clinical guidelines of the united European gastroenterology and European society for neurogastroenterology and motility', United European Gastroenterology Journal, 10(6), pp. 556-584. doi: 10.1002/ueg2.12259 https://doi.org/10.1002/ueg2.12259.en_US
dc.identifier.issn2050-6414
dc.identifier.issn2050-6406
dc.identifier.urihttp://hdl.handle.net/20.500.12904/18413
dc.description.abstractIrritable bowel syndrome with diarrhoea (IBS-D) and functional diarrhoea (FDr) are the two major functional bowel disorders characterized by diarrhoea. In spite of their high prevalence, IBS-D and FDr are associated with major uncertainties, especially regarding their optimal diagnostic work-up and management. A Delphi consensus was performed with experts from 10 European countries who conducted a literature summary and voting process on 31 statements. Quality of evidence was evaluated using the grading of recommendations, assessment, development, and evaluation criteria. Consensus (defined as >80% agreement) was reached for all the statements. The panel agreed with the potential overlapping of IBS-D and FDr. In terms of diagnosis, the consensus supports a symptom-based approach also with the exclusion of alarm symptoms, recommending the evaluation of full blood count, C-reactive protein, serology for coeliac disease, and faecal calprotectin, and consideration of diagnosing bile acid diarrhoea. Colonoscopy with random biopsies in both the right and left colon is recommended in patients older than 50 years and in presence of alarm features. Regarding treatment, a strong consensus was achieved for the use of a diet low fermentable oligo-, di-, monosaccharides and polyols, gut-directed psychological therapies, rifaximin, loperamide, and eluxadoline. A weak or conditional recommendation was achieved for antispasmodics, probiotics, tryciclic antidepressants, bile acid sequestrants, 5-hydroxytryptamine-3 antagonists (i.e. alosetron, ondansetron, or ramosetron). A multinational group of European experts summarized the current state of consensus on the definition, diagnosis, and management of IBS-D and FDr. Copyright © 2022 The Authors. United European Gastroenterology Journal published by Wiley Periodicals LLC on behalf of United European Gastroenterology.
dc.description.urihttps://doi.org/10.1002/ueg2.12259en_US
dc.language.isoenen_US
dc.subjectIrritable bowel syndromeen_US
dc.subjectDiarrhoeaen_US
dc.subjectDelphi methoden_US
dc.titleFunctional bowel disorders with diarrhoea: Clinical guidelines of the united European gastroenterology and European society for neurogastroenterology and motilityen_US
dc.typeArticleen_US
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US
rioxxterms.versionVoRen_US
rioxxterms.versionofrecord10.1002/ueg2.12259en_US
rioxxterms.typeJournal Article/Reviewen_US
refterms.dateFCD2024-03-20T11:00:44Z
refterms.versionFCDVoR
refterms.dateFOA2024-03-20T11:00:44Z
refterms.panelUnspecifieden_US
html.description.abstractIrritable bowel syndrome with diarrhoea (IBS-D) and functional diarrhoea (FDr) are the two major functional bowel disorders characterized by diarrhoea. In spite of their high prevalence, IBS-D and FDr are associated with major uncertainties, especially regarding their optimal diagnostic work-up and management. A Delphi consensus was performed with experts from 10 European countries who conducted a literature summary and voting process on 31 statements. Quality of evidence was evaluated using the grading of recommendations, assessment, development, and evaluation criteria. Consensus (defined as >80% agreement) was reached for all the statements. The panel agreed with the potential overlapping of IBS-D and FDr. In terms of diagnosis, the consensus supports a symptom-based approach also with the exclusion of alarm symptoms, recommending the evaluation of full blood count, C-reactive protein, serology for coeliac disease, and faecal calprotectin, and consideration of diagnosing bile acid diarrhoea. Colonoscopy with random biopsies in both the right and left colon is recommended in patients older than 50 years and in presence of alarm features. Regarding treatment, a strong consensus was achieved for the use of a diet low fermentable oligo-, di-, monosaccharides and polyols, gut-directed psychological therapies, rifaximin, loperamide, and eluxadoline. A weak or conditional recommendation was achieved for antispasmodics, probiotics, tryciclic antidepressants, bile acid sequestrants, 5-hydroxytryptamine-3 antagonists (i.e. alosetron, ondansetron, or ramosetron). A multinational group of European experts summarized the current state of consensus on the definition, diagnosis, and management of IBS-D and FDr. Copyright © 2022 The Authors. United European Gastroenterology Journal published by Wiley Periodicals LLC on behalf of United European Gastroenterology.en_US
rioxxterms.funder.project94a427429a5bcfef7dd04c33360d80cden_US


Files in this item

Thumbnail
Name:
Functional bowel disorders with ...
Size:
865.4Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record